CXCL9 and its Receptor CXCR3, an Important Link Between Inflammation and Cardiovascular Risks in RA Patients

• Published in: Inflammation Vol. 46; no. 6; pp. 2374 - 2385
• Main Authors: Shamsi, Afsaneh, Roghani, Seyed Askar, Abdan, Zahra, Soufivand, Parviz, Pournazari, Mehran, Bahrehmand, Fariborz, Vafaei, Ali, Salari, Nader, Soroush, Masood Ghasemzade, Taghadosi, Mahdi
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.12.2023; Springer Nature B.V
• Subjects: Biomedical and Life Sciences; Biomedicine; Blood pressure; Cardiovascular diseases; CXCR3 protein; Gene expression; High density lipoprotein; Immunology; Inflammation; Internal Medicine; Low density lipoprotein; Pathogenesis; Pathology; Pharmacology/Toxicology; Plasma; Plasma levels; Rheumatoid arthritis; Rheumatology; Risk factors; CVD; CXCL9; rheumatoid arthritis; CXCR3

Cardiovascular disease (CVD) is the most common cause of mortality in rheumatoid arthritis (RA), and Inflammation has a decisive role in its pathogenesis. CXCL9 contributes to multi aspects of inflammatory reactions associated with the pathogenesis of CVD. In the current study, we evaluated the asso...